Mark L. Ormiston
Hills Rd
Cambridge, ENG, United Kingdom
Cambridge, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 41 publications
Circular RNA Profiling Identifies circ5078 as a BMPR2-Derived Regulator of Endothelial Proliferation and Stress Responses.
Journal: Arteriosclerosis, thrombosis, and vascular biology
Published: August 07, 2025
Bmpr2 Loss in the Vascular Endothelium Enhances Neoangiogenesis and Growth of Lung Metastatic Lesions in a Mouse Model of Breast Cancer.
Journal: Journal of cellular biochemistry
Published: January 07, 2025
Novel Drp1 GTPase Inhibitor, Drpitor1a: Efficacy in Pulmonary Hypertension.
Journal: Hypertension (Dallas, Tex. : 1979)
Published: August 20, 2024
Addressing Natural Killer Cell Dysfunction and Plasticity in Cell-Based Cancer Therapeutics.
Journal: Cancers
Published: February 02, 2023
Targeting BMPR-II in pulmonary arterial hypertension: a case of Hercules versus the Hydra?
Journal: Expert opinion on therapeutic targets
Published: January 13, 2023
IFN-β activates cytotoxic function of human natural killer cells toward IL-27 and poly(I:C) stimulated PC3 and DU145 cells.
Journal: Cellular immunology
Published: January 13, 2023
Oh NO! Loss of PHD2 leads to "radical" changes in the lung vasculature.
Journal: The European respiratory journal
Published: September 14, 2022
Impaired Interleukin-15 Signaling via BMPR2 Loss Drives Natural Killer Cell Deficiency and Pulmonary Hypertension.
Journal: Hypertension (Dallas, Tex. : 1979)
Published: August 31, 2022
Evolving Concepts in Endothelial Pathobiology of Pulmonary Arterial Hypertension.
Journal: Hypertension (Dallas, Tex. : 1979)
Published: May 18, 2022
Novel Pathways for Targeting Tumor Angiogenesis in Metastatic Breast Cancer.
Journal: Frontiers in oncology
Published: September 07, 2021
Last Updated: 09/26/2026